| Info |
|---|
Welcome!The Million Hearts Learning Lab is a learning series focused on cardiovascular disease prevention and management topics. The series is open to clinicians, quality improvement, and other interested staff across the country. Click here for previous Learning Lab recordings and information. Register for the Million Hearts Learning Lab Series here!Don't forget to do your pre-work!In advance of each live Q&A session, please listen to the brief (10-13 minutes) audio recording and submit questions to the session faculty. These activities are part of the total time required to receive Continuing Education (CE) credits. And, this will allow you to get the most out of the session and for the session to be tailored to the needs and interests of the audience. |
Topic | Date | Pre-Work | CE Information | Recordings and Materials | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Using Self-Measured Blood Pressure Monitoring to Improve Maternal Health Equity and Reduce Maternal Mortality | January 11, 2024 |
|
| |||||||||||||
A Statin is Indicated for your Patient - Getting There Together | March 7, 2024 | Live Activity: In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and the National Association of Community Health Centers. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CNE: The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours. CPE: The Centers for Disease Control and Prevention designated this Knowledge based event for pharmacists to receive 1.0 CEUs in pharmacy education. The Universal Activity Number isJA4008229-9999-24-046-L01-P. Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program. CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.0. Continuing Competency credits available are 1.0.CDC provider number 98614. DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use. CDC, our planners, and our content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients. Content will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC did not accept financial or in-kind support from any ineligible company for this continuing education activity. | ||||||||||||||
Breakthrough Activities for Improving Hypertension and Cholesterol Outcomes | April 11, 2024 | |||||||||||||||
Strategies to Prevent and Optimize Care for Hypertension Disorders of Pregnancy | July 11, 2024 |
In support of improving patient care, this activity has been planned and implemented by Centers for Disease Control and Prevention and the National Association of Community Health Centers. The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention designates this activity for 1.0 nursing contact hours.
CPE: The Centers for Disease Control and Prevention designated this Knowledge based event for pharmacists to receive 1.0 CEUs in pharmacy education. The Universal Activity Number isJA4008229-9999-24-046-L01-P.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.0. Continuing Competency credits available are 1.0.CDC provider number 98614.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and our content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from any ineligible company for this continuing education activity.